FDA Investigator Zhang Zhao, PhD
Zhang Zhao, PhD has conducted inspections on 1 sites in 1 countries as of 18 Jan 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
18 Jan 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Zhang Zhao, PhD:
Bo Chi, PhD,
Brian A Roelofs,
Dilip Devineni, PhD,
Eric M Mueller, PharmD,
Hamet M Toure, PharmD MPH,
Ian L Mcwilliams,
Jill J Tillman,
Joseph A Piechocki,
Joslyn K Brunelle, PhD,
Kalavati Suvarna, PhD,
Lauren N Howard,
Laurie Graham,
Massod Rahimi, PhD,
Michael Shanks, MS,
Michele L Glendenning,
Michele Perry Williams,
Monica E Murie,
Richard Ledwidge (nmi), PhD,
Robert J Ham,
Sidney B Priesmeyer,
Steven D Kehoe,
Tara L Greene,
Tara L King,
Warren J Lopicka,
Xiaoshi N Wang,
Yongmin Liu
Zhang Zhao, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2023 | FDA 483 | Patheon Biologics LLC - Form 483, 2023-01-24 |
December, 2023 | EIR | Suzhou Suncadia Biopharmaceuticals Co., Ltd - EIR, 2024-07-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more